cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.22620154
title: Additional file 1 of Genome-wide association study of leaf-related traits in tea plant in Guizhou based on genotyping-by-sequencing

description: Additional file 1: Figure S1. Dynamics of population structure under different K (K = 2-9) values of 338 tea accessions. Figure S2. The Q-Q plots and Manhattan plots of other models of 4 traits except the optimal model. (A1) MLZ-2019-cMLM-Q+K; (A2) MLZ-2019-GLM-P; (A3) MLZ-2019-GLM-Q; (A4) MLZ-2019-MLM-P+K; (A5) MLZ-2019-MLM-Q+K; (B1) MLZ-2020-cMLM-Q+K; (B2) MLZ- 2020-GLM-P; (B3) MLZ-2020-GLM-Q; (B4) MLZ-2020-MLM-P+K; (B5) MLZ-2020-MLM-Q+K; (C1) MLZ-2021-cMLM-Q+K; (C2) MLZ-2021-GLM-P; (C3) MLZ-2021-GLM-Q; (C4) MLZ-2021-MLM-P+K; (C5) MLZ-2021-MLM-Q+K; (D1) MLC-cMLM-P+K; (D2) MLC-cMLM-Q+K; (D3) MLC-GLM-P; (D4) MLC-MLM-P+K; (D5) MLC-MLM-Q+K; (E1) MLS-cMLM-Q+K; (E2) MLS-GLM-P; (E3) MLS-GLM-Q; (E4) MLS-MLM-P+K; (E5) MLS-MLM-Q+K; (F1) MLT-cMLM-P+K; (F2) MLT-cMLM-Q+K; (F3) MLT-GLM-Q; (F4) MLT-MLM-P+K; (F5) MLT-MLM-Q+K. Figure S3. The labeled complete gels of PCR products of six tea accessions using the dCAPS primer. Table S1. The quality control (QC) data of each sample. Table S2. Genotyping of 100,829 SNPs based on GBS in 168 tea accessions. Table S3. Genotyping of 100,829 SNPs based on GBS in 170 tea accessions. Table S4. Distribution information of 100,829 SNPs on 15 chromosomes of tea plant.Table S5. Information of 338 tea accessions used in the present study. Table S6. Statistics of the number and ratio of the accessions of species, and both cultivation status in five inferred populations.Table S7. Analysis of TEA005350.1 gene expression of 15 tea plant accessions. Table S8. Analysis of TEA027527.1 gene expression of 20 tea plant accessions. Table S9. Four leaf phenotypic traits (mature leaf size, mature leaf color, mature leaf shape and mature leaf texture) data and their assignment of 338 tea accessions in 2019, 2020 and 2021, respectively.
DOI: 10.6084/m9.figshare.22620235.v1
title: Additional file 4 of Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma

description: Additional file 4 .
DOI: 10.6084/m9.figshare.20522738
title: Additional file 2 of Cytochemical and comparative transcriptome analyses elucidate the formation and ecological adaptation of three types of pollen coat in Zingiberaceae

description: Additional file 2: Table S7. Detection of selection for pollen coat formation genes in Caulokaempferia coenobialis (Cco), Hornstedtia hainanensis (Hhn) Branch using Branch-site Model of PAML.
DOI: 10.6084/m9.figshare.14708104
title: Additional file 3 of A designathon to co-create community-driven HIV self-testing services for Nigerian youth: findings from a participatory event

description: Additional file 3: Supplement 3. Judges' scores for all teams at the designathon: Nigeria 2019*.
DOI: 10.5281/zenodo.7495193
title: Data-set of the partial pressure of CO2,  dissolved concentrations of CH4, N2O, NO3-, NO2- and NH4+, specific conductivity and water temperature in the rivers and streams of the Napo River basin in Ecuador (2018, 2019, 2020, 2021)

description: Data-set consists of two files:


- data_ghgs.xlsx : Time-stamped and georeferenced data-set of the partial pressure of CO2 (pCO2 in ppm), dissolved CH4 concentration (CH4 in nmol/L), dissolved N2O concentration (N2O in nmol/L), specific (Sp.) conductivity (in µS/cm), water temperature (in °C), dissolved nitrate concentration (NO3- in µmol/L), dissolved nitrite concentration (NO2- in µmol/L), and dissolved ammonia concentration (NH4+ in µmol/L) in the rivers and streams of the Napo River basin in Ecuador (October 2018 and 2019, January 2019 and 2020, April 2019 and 2021, July 2019 and 2020). Gas measurements were made by headspace equilibration directly in the field with a infra-red gas analyser for CO2 and in the lab with a gas chromatograph for CH4 and N2O. NO3-, NO2- and NH4+ were measured with standard colometric procedures. Sampling and analytical protocols are provided here https://doi.org/10.5194/bg-16-3801-2019


- RiverATLAS.xlsx: hydro-environmental data for the sampled streams extracted from RiverATLAS (https://www.nature.com/articles/s41597-019-0300-6). Data codes and units are available here: https://data.hydrosheds.org/file/technical-documentation/HydroATLAS_TechDoc_v10_1.pdf


First column of each of the two files provides station ID allowing to merge both data-sets.
DOI: 10.5281/zenodo.10634016
title: O'SMIRLARDA JINOYAT MOTIVLARINI KELTIRIB CHIQARUVCHI IJTIMOIY-PSIXOLOGIK OMILLAR
DOI: 10.5281/zenodo.10634017
title: O'SMIRLARDA JINOYAT MOTIVLARINI KELTIRIB CHIQARUVCHI IJTIMOIY-PSIXOLOGIK OMILLAR
DOI: 10.5281/zenodo.6527837
title: Data-set of the partial pressure of CO2,  dissolved concentrations of CH4, N2O, NO3-, NO2- and NH4+, specific conductivity and water temperature in the rivers and streams of the Napo River basin in Ecuador (2018, 2019, 2020, 2021)

description: Data-set consists of two files:


- data_ghgs.xlsx : Time-stamped and georeferenced data-set of the partial pressure of CO2 (pCO2 in ppm), dissolved CH4 concentration (CH4 in nmol/L), dissolved N2O concentration (N2O in nmol/L), specific (Sp.) conductivity (in µS/cm), water temperature (in °C), dissolved nitrate concentration (NO3- in µmol/L), dissolved nitrite concentration (NO2- in µmol/L), and dissolved ammonia concentration (NH4+ in µmol/L) in the rivers and streams of the Napo River basin in Ecuador (October 2018 and 2019, January 2019 and 2020, April 2019 and 2021, July 2019 and 2020). Gas measurements were made by headspace equilibration directly in the field with a infra-red gas analyser for CO2 and in the lab with a gas chromatograph for CH4 and N2O. NO3-, NO2- and NH4+ were measured with standard colometric procedures. Sampling and analytical protocols are provided here https://doi.org/10.5194/bg-16-3801-2019


- RiverATLAS.xlsx: hydro-environmental data for the sampled streams extracted from RiverATLAS (https://www.nature.com/articles/s41597-019-0300-6). Data codes and units are available here: https://data.hydrosheds.org/file/technical-documentation/HydroATLAS_TechDoc_v10_1.pdf


First column of each of the two files provides station ID allowing to merge both data-sets.
DOI: 10.6084/m9.figshare.22620226
title: Additional file 1 of Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma

description: Additional file 1: Table S1. Down-regulated and up-regulated differentially expressed genes in three cohorts.
DOI: 10.6084/m9.figshare.12134469
title: Additional file 2 of Molecular cytogenetic characterization of a novel wheat–Psathyrostachys huashanica Keng T3DS-5NsL•5NsS and T5DL-3DS•3DL dual translocation line with powdery mildew resistance

description: Additional file 2. Table S1 TR77-SSR Analysis.
DOI: 10.6084/m9.figshare.12134478.v1
title: Additional file 3 of Molecular cytogenetic characterization of a novel wheat–Psathyrostachys huashanica Keng T3DS-5NsL•5NsS and T5DL-3DS•3DL dual translocation line with powdery mildew resistance

description: Additional file 3. Table S2 TR77-15K SNP array.
DOI: 10.6084/m9.figshare.22620281.v1
title: Additional file 3 of Integrated analysis identifies oxidative stress-related lncRNAs associated with progression and prognosis in colorectal cancer

description: Additional file 3. The reference list of MSI scores.
DOI: 10.6084/m9.figshare.12134265.v1
title: Additional file 2 of Identification and application of piwi-interacting RNAs from seminal plasma exosomes in Cynoglossus semilaevis

description: Additional file 2. List of 7070 novel piRNAs categories in ZZ donorgroup.
DOI: 10.6084/m9.figshare.22620238
title: Additional file 1 of Multi-omic characterization of the maize GPI synthesis mutant gwt1 with defects in kernel development

description: Supplementary Material 1
DOI: 10.6084/m9.figshare.25187753
title: Supplementary material for “Extending Voting Rights to Emigrants: A Global Analysis of Actors, Processes and Outcomes”, by Nathan W. Allen and Elizabeth Iams Wellman, published in <i>Diaspora Studies</i> (BDIA), Volume 17, Issue 1 (2024)

description: These are the supplementary materials for an article published in <i>Diaspora Studies</i> (BDIA), Volume 17, Issue 1 (2024) entitled “Extending Voting Rights to Emigrants: A Global Analysis of Actors, Processes and Outcomes”, by Nathan W. Allen and Elizabeth Iams Wellman, with DOI: 10.1163/09763457-bja10078. Since 1980, most states have granted voting rights to citizens living abroad. Although cross-national research focuses on when and where emigrant enfranchisement occurs, there has been little systematic attention to the variation in how enfranchisement occurs (for example, by constitutional amendment) and who extends these rights (international actors, for example). We argue that the variation in legal modalities and political actors is important for understanding why enfranchisement occurs and helps to account for the subsequent institutional inclusion—and exclusion—of emigrant voters. Using an original dataset which documents every extension of non-citizen voting rights (n = 153), we uncover variations in legal processes, regionally and over time. Although legislation is the most common enfranchisement pathway, judiciaries have become increasingly involved since 2000, particularly in Asian and African countries. Furthermore, emigrant enfranchisements involving constitutional reforms or plebiscites tend to be the most durable, whereas enfranchisements by international agreement are most prone to policy reversals. These appendices consist of the raw data used in this study.<br>
DOI: 10.6084/m9.figshare.25187753.v1
title: Supplementary material for “Extending Voting Rights to Emigrants: A Global Analysis of Actors, Processes and Outcomes”, by Nathan W. Allen and Elizabeth Iams Wellman, published in <i>Diaspora Studies</i> (BDIA), Volume 17, Issue 1 (2024)

description: These are the supplementary materials for an article published in <i>Diaspora Studies</i> (BDIA), Volume 17, Issue 1 (2024) entitled “Extending Voting Rights to Emigrants: A Global Analysis of Actors, Processes and Outcomes”, by Nathan W. Allen and Elizabeth Iams Wellman, with DOI: 10.1163/09763457-bja10078. Since 1980, most states have granted voting rights to citizens living abroad. Although cross-national research focuses on when and where emigrant enfranchisement occurs, there has been little systematic attention to the variation in how enfranchisement occurs (for example, by constitutional amendment) and who extends these rights (international actors, for example). We argue that the variation in legal modalities and political actors is important for understanding why enfranchisement occurs and helps to account for the subsequent institutional inclusion—and exclusion—of emigrant voters. Using an original dataset which documents every extension of non-citizen voting rights (n = 153), we uncover variations in legal processes, regionally and over time. Although legislation is the most common enfranchisement pathway, judiciaries have become increasingly involved since 2000, particularly in Asian and African countries. Furthermore, emigrant enfranchisements involving constitutional reforms or plebiscites tend to be the most durable, whereas enfranchisements by international agreement are most prone to policy reversals. These appendices consist of the raw data used in this study.<br>
DOI: 10.6084/m9.figshare.22620122.v1
title: Additional file 1 of Proteins in pregnant swine serum promote the African swine fever virus replication: an iTRAQ-based quantitative proteomic analysis

description: Additional file 1. Differentially expressed proteins in the serum of pregnant and non-pregnant swine.
DOI: 10.6084/m9.figshare.22623080.v1
title: Additional file 3 of The distribution characteristics of global blaOXA-carrying Klebsiella pneumoniae

description: Additional file 3: TableS2. The accession number and the web link to datasets for the provided name ofall the strains in this study.
DOI: 10.6084/m9.figshare.22620241.v1
title: Additional file 2 of Multi-omic characterization of the maize GPI synthesis mutant gwt1 with defects in kernel development

description: Supplementary Material 2
DOI: 10.6084/m9.figshare.22620275
title: Additional file 1 of Integrated analysis identifies oxidative stress-related lncRNAs associated with progression and prognosis in colorectal cancer

description: Additional file 1. The List of 789 oxidative stress-related genes.
DOI: 10.6084/m9.figshare.22623080
title: Additional file 3 of The distribution characteristics of global blaOXA-carrying Klebsiella pneumoniae

description: Additional file 3: TableS2. The accession number and the web link to datasets for the provided name ofall the strains in this study.
DOI: 10.6084/m9.figshare.22620226.v1
title: Additional file 1 of Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma

description: Additional file 1: Table S1. Down-regulated and up-regulated differentially expressed genes in three cohorts.
DOI: 10.6084/m9.figshare.22620281
title: Additional file 3 of Integrated analysis identifies oxidative stress-related lncRNAs associated with progression and prognosis in colorectal cancer

description: Additional file 3. The reference list of MSI scores.
DOI: 10.6084/m9.figshare.22620154.v1
title: Additional file 1 of Genome-wide association study of leaf-related traits in tea plant in Guizhou based on genotyping-by-sequencing

description: Additional file 1: Figure S1. Dynamics of population structure under different K (K = 2-9) values of 338 tea accessions. Figure S2. The Q-Q plots and Manhattan plots of other models of 4 traits except the optimal model. (A1) MLZ-2019-cMLM-Q+K; (A2) MLZ-2019-GLM-P; (A3) MLZ-2019-GLM-Q; (A4) MLZ-2019-MLM-P+K; (A5) MLZ-2019-MLM-Q+K; (B1) MLZ-2020-cMLM-Q+K; (B2) MLZ- 2020-GLM-P; (B3) MLZ-2020-GLM-Q; (B4) MLZ-2020-MLM-P+K; (B5) MLZ-2020-MLM-Q+K; (C1) MLZ-2021-cMLM-Q+K; (C2) MLZ-2021-GLM-P; (C3) MLZ-2021-GLM-Q; (C4) MLZ-2021-MLM-P+K; (C5) MLZ-2021-MLM-Q+K; (D1) MLC-cMLM-P+K; (D2) MLC-cMLM-Q+K; (D3) MLC-GLM-P; (D4) MLC-MLM-P+K; (D5) MLC-MLM-Q+K; (E1) MLS-cMLM-Q+K; (E2) MLS-GLM-P; (E3) MLS-GLM-Q; (E4) MLS-MLM-P+K; (E5) MLS-MLM-Q+K; (F1) MLT-cMLM-P+K; (F2) MLT-cMLM-Q+K; (F3) MLT-GLM-Q; (F4) MLT-MLM-P+K; (F5) MLT-MLM-Q+K. Figure S3. The labeled complete gels of PCR products of six tea accessions using the dCAPS primer. Table S1. The quality control (QC) data of each sample. Table S2. Genotyping of 100,829 SNPs based on GBS in 168 tea accessions. Table S3. Genotyping of 100,829 SNPs based on GBS in 170 tea accessions. Table S4. Distribution information of 100,829 SNPs on 15 chromosomes of tea plant.Table S5. Information of 338 tea accessions used in the present study. Table S6. Statistics of the number and ratio of the accessions of species, and both cultivation status in five inferred populations.Table S7. Analysis of TEA005350.1 gene expression of 15 tea plant accessions. Table S8. Analysis of TEA027527.1 gene expression of 20 tea plant accessions. Table S9. Four leaf phenotypic traits (mature leaf size, mature leaf color, mature leaf shape and mature leaf texture) data and their assignment of 338 tea accessions in 2019, 2020 and 2021, respectively.
DOI: 10.6084/m9.figshare.20038880
title: Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin

description: The aim of the present study was to assess the bioequivalence of two cephalexin tablet formulations available in the Brazilian market (product A as reference formulation and product B as test formulation). Dissolution efficiency (DE%) was calculated for both formulations to evaluate their in vitrobiopharmaceutical features. The oral bioequivalence study was performed in twenty-four healthy volunteers in a crossover design. Single oral dose (tablet containing 500 mg of cephalexin) of each product was administered with two weeks of washout period. Urinary concentrations of cephalexin were measured by high-performance liquid chromatography (HPLC) method and pharmacokinetics parameters were estimated by urinary excretion data. The bioequivalence was determined by the following parameters: the cumulative amount of cephalexin excreted in the urine, the total amount of cephalexin excreted in the urine and the maximum urinary excretion rate of cephalexin. DE values of immediate-release cephalexin tablets (500 mg) were 68.69±4.18% for product A and 71.03±6.63% for product B. Regarding the dissolution test of the two brands (A and B) analysed, both were in compliance with the official pharmacopeial specifications, since the dissolution of both formulations was superior to 80% of the amount declared in the label after 45 minutes of test (A=92.09%±1.84; B=92.84%±1.08). The results obtained indicated that the products A and B are pharmaceutical equivalents. Confidence intervals for the pharmacokinetic parameters were in compliance with the international standards, indicating that products A and B can be considered bioequivalents and, therefore, interchangeable.
DOI: 10.6084/m9.figshare.20038880.v1
title: Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin

description: The aim of the present study was to assess the bioequivalence of two cephalexin tablet formulations available in the Brazilian market (product A as reference formulation and product B as test formulation). Dissolution efficiency (DE%) was calculated for both formulations to evaluate their in vitrobiopharmaceutical features. The oral bioequivalence study was performed in twenty-four healthy volunteers in a crossover design. Single oral dose (tablet containing 500 mg of cephalexin) of each product was administered with two weeks of washout period. Urinary concentrations of cephalexin were measured by high-performance liquid chromatography (HPLC) method and pharmacokinetics parameters were estimated by urinary excretion data. The bioequivalence was determined by the following parameters: the cumulative amount of cephalexin excreted in the urine, the total amount of cephalexin excreted in the urine and the maximum urinary excretion rate of cephalexin. DE values of immediate-release cephalexin tablets (500 mg) were 68.69±4.18% for product A and 71.03±6.63% for product B. Regarding the dissolution test of the two brands (A and B) analysed, both were in compliance with the official pharmacopeial specifications, since the dissolution of both formulations was superior to 80% of the amount declared in the label after 45 minutes of test (A=92.09%±1.84; B=92.84%±1.08). The results obtained indicated that the products A and B are pharmaceutical equivalents. Confidence intervals for the pharmacokinetic parameters were in compliance with the international standards, indicating that products A and B can be considered bioequivalents and, therefore, interchangeable.
DOI: 10.6084/m9.figshare.20038892.v1
title: Stir bar-sorptive extraction, solid phase extraction and liquid-liquid extraction for levetiracetam determination in human plasma: comparing recovery rates

description: Levetiracetam (LEV), an antiepileptic drug (AED) with favorable pharmacokinetic profile, is increasingly being used in clinical practice, although information on its metabolism and disposition are still being generated. Therefore a simple, robust and fast liquid-liquid extraction (LLE) followed by high-performance liquid chromatography method is described that could be used for both pharmacokinetic and therapeutic drug monitoring (TDM) purposes. Moreover, recovery rates of LEV in plasma were compared among LLE, stir bar-sorptive extraction (SBSE), and solid-phase extraction (SPE). Solvent extraction with dichloromethane yielded a plasma residue free from usual interferences such as commonly co-prescribed AEDs, and recoveries around 90% (LLE), 60% (SPE) and 10% (SBSE). Separation was obtained using reverse phase Select B column with ultraviolet detection (235 nm). Mobile phase consisted of methanol:sodium acetate buffer 0.125 M pH 4.4 (20:80, v/v). The method was linear over a range of 2.8-220.0 µg mL<sup>-1</sup>. The intra- and inter-assay precision and accuracy were studied at three concentrations; relative standard deviation was less than 10%. The limit of quantification was 2.8 µg mL<sup>-1</sup>. This robust method was successfully applied to analyze plasma samples from patients with epilepsy and therefore might be used for pharmacokinetic and TDM purposes.
DOI: 10.6084/m9.figshare.20038892
title: Stir bar-sorptive extraction, solid phase extraction and liquid-liquid extraction for levetiracetam determination in human plasma: comparing recovery rates

description: Levetiracetam (LEV), an antiepileptic drug (AED) with favorable pharmacokinetic profile, is increasingly being used in clinical practice, although information on its metabolism and disposition are still being generated. Therefore a simple, robust and fast liquid-liquid extraction (LLE) followed by high-performance liquid chromatography method is described that could be used for both pharmacokinetic and therapeutic drug monitoring (TDM) purposes. Moreover, recovery rates of LEV in plasma were compared among LLE, stir bar-sorptive extraction (SBSE), and solid-phase extraction (SPE). Solvent extraction with dichloromethane yielded a plasma residue free from usual interferences such as commonly co-prescribed AEDs, and recoveries around 90% (LLE), 60% (SPE) and 10% (SBSE). Separation was obtained using reverse phase Select B column with ultraviolet detection (235 nm). Mobile phase consisted of methanol:sodium acetate buffer 0.125 M pH 4.4 (20:80, v/v). The method was linear over a range of 2.8-220.0 µg mL<sup>-1</sup>. The intra- and inter-assay precision and accuracy were studied at three concentrations; relative standard deviation was less than 10%. The limit of quantification was 2.8 µg mL<sup>-1</sup>. This robust method was successfully applied to analyze plasma samples from patients with epilepsy and therefore might be used for pharmacokinetic and TDM purposes.
DOI: 10.6084/m9.figshare.20038893
title: Production of vegetable oil blends and structured lipids and their effect on wound healing

description: Two oil blends (sunflower/canola oils 85/15 (BL1) and canola/linseed oils 70/30 (BL2)), were prepared and enzymatically interesterified to be applied to surgically-induced wounds in rats. Following surgery, the animals were submitted to the Treatment with Physiological Saline (TPS) (control group), Blends (TBL), and Structured Lipids (TSL). The control group (TPS) received physiological saline solution for 15 days. In TBL, BL1 was administered during the inflammation phase (days 0-3) and BL2 in the tissue formation and remodeling phase (days 4-15). In TSL, Structured Lipid 1 (SL1) and Structured Lipid 2 (SL2) were used instead of BL1 and BL2, respectively. The aim of this study was to compare wound closure evolution among rats treated with the blends or structured lipids versus control rats treated with physiological saline. The wound healing process was evaluated by measuring the wound areas along the treatments and the concentrations of cytokines. An increase in the areas of wounds treated with the blends and structured lipids in the inflammatory phase was observed, followed by a steeper closure curve compared to wounds treated with physiological saline. The changes observed during the inflammatory phase suggest a potential therapeutic application in cutaneous wound healing which should be further investigated.